Get the Stockscreener App
1.78
4.81%
-0.09
Pre-market:
1.77
-0.01
-0.56%
Mustang Bio Inc stock is traded at $1.78, with a volume of 114.59K.
It is down -4.81% in the last 24 hours and down -26.45% over the past month.
Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.
See More
Previous Close:
$1.87
Open:
$1.8
24h Volume:
114.59K
Relative Volume:
0.02
Market Cap:
$6.29M
Revenue:
-
Net Income/Loss:
$-23.42M
P/E Ratio:
-0.0228
EPS:
-78
Net Cash Flow:
$-16.67M
1W Performance:
+17.11%
1M Performance:
-26.45%
6M Performance:
-36.43%
1Y Performance:
-89.21%
1-Day Range:
$1.68
$1.8364
1-Week Range:
$1.47
$1.88
52-Week Range:
$0.8926
$21.95
Mustang Bio Inc Stock (MBIO) Company Profile
Name
Mustang Bio Inc
Sector
Industry
Phone
(781) 652-4500
Address
377 PLANTATION STREET, WORCESTER, NY
Compare MBIO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MBIO
Mustang Bio Inc
|
1.78 | 8.19M | 0 | -23.42M | -16.67M | -78.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
390.30 | 101.51B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
565.97 | 59.52B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
442.73 | 56.69B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
652.43 | 39.57B | 3.06B | 1.28B | -614.78M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
309.69 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Mustang Bio Inc Stock (MBIO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-18-21 | Initiated | BTIG Research | Buy |
| Oct-02-20 | Initiated | B. Riley FBR | Buy |
| Nov-20-19 | Initiated | Cantor Fitzgerald | Overweight |
| Aug-13-19 | Initiated | H.C. Wainwright | Buy |
| Jun-21-19 | Initiated | Cantor Fitzgerald | Overweight |
| Dec-21-17 | Initiated | Oppenheimer | Outperform |
View All
Mustang Bio Inc Stock (MBIO) Latest News
What’s next for Mustang Bio Inc. stock priceEarnings Recap Summary & Short-Term High Return Strategies - Newser
Published on: 2025-08-14 20:51:45 - Newser
Why Mustang Bio Inc. stock attracts strong analyst attentionWeekly Trade Summary & Community Consensus Trade Alerts - sundaytimes.kr
What makes Mustang Bio Inc. stock price move sharply2025 Analyst Calls & Capital Protection Trading Alerts - Newser
Using data filters to optimize entry into Mustang Bio Inc.Weekly Stock Recap & Accurate Entry/Exit Alerts - Newser
What moving averages say about Mustang Bio Inc.July 2025 Action & AI Enhanced Trading Alerts - Newser
Does Mustang Bio Inc. fit your quant trading modelPortfolio Performance Report & Free Accurate Trade Setup Notifications - Newser
Is Mustang Bio Inc. showing signs of accumulationMarket Growth Summary & Free Weekly Chart Analysis and Trade Guides - Newser
Market reaction to Mustang Bio Inc.’s recent newsJuly 2025 Review & Reliable Price Breakout Alerts - Newser
Analyzing recovery setups for Mustang Bio Inc. investorsMarket Trend Review & Free Daily Entry Point Trade Alerts - Newser
What indicators show strength in Mustang Bio Inc.Weekly Profit Recap & Stepwise Trade Signal Guides - Newser
Chart based analysis of Mustang Bio Inc. trendsLong Setup & Technical Entry and Exit Alerts - Newser
Applying chart zones and confluence areas to Mustang Bio Inc.Entry Optimization Tool with Screener Logic - Newser
Signal strength of Mustang Bio Inc. stock in tech scannersChart Signal and Short-Term Forecast Tracker - Newser
Can swing trading help recover from Mustang Bio Inc. lossesFree Sector Rotation Based Trading Opportunities - Newser
Mustang Bio (NASDAQ:MBIO) Shares Up 6% – What’s Next? - Defense World
Applying Elliott Wave Theory to Mustang Bio Inc.AI Powered Buy Point Forecast Planner - Newser
Combining machine learning predictions for Mustang Bio Inc.Market Timing Strategy with Technical Filters - Newser
Is it too late to sell Mustang Bio Inc.High Conviction Stock Long-Term Summary - Newser
Mustang Bio MBIO 2025Q2 Earnings Preview Upside Potential on Strategic Advancements in Biotechnology - AInvest
MUSTANG BIO, INC. SEC 10-Q Report - TradingView
Real Time Chart Alerts Flash Bullish on Mustang Bio Inc.Free Consultation - beatles.ru
Is it the right time to buy Mustang Bio Inc. stockRapid wealth multiplication - Jammu Links News
Why is Mustang Bio Inc. stock attracting strong analyst attentionGet real-time alerts on top stocks - Jammu Links News
What analysts say about Mustang Bio Inc. stockTremendous gains - Jammu Links News
Is Mustang Bio Inc. a growth stock or a value stockInvest smarter with daily stock recommendations - Jammu Links News
What catalysts could drive Mustang Bio Inc. stock higher in 2025Discover hidden gems in the stock market - Jammu Links News
What institutional investors are buying Mustang Bio Inc. stockDiscover high-growth stocks for your portfolio - Jammu Links News
What drives Mustang Bio Inc. stock priceGet exclusive market analysis for investors - Jammu Links News
Should I hold or sell Mustang Bio Inc. stock in 2025Discover stock picks with superior returns - Jammu Links News
What are analysts’ price targets for Mustang Bio Inc. in the next 12 monthsBuild wealth with steady, reliable stocks - Jammu Links News
What are the latest earnings results for Mustang Bio Inc.Get real-time alerts on high-potential stocks - Jammu Links News
When is Mustang Bio Inc. stock expected to show significant growthFree Predictions - Jammu Links News
Building trade automation scripts for Mustang Bio Inc.Real-Time Entry Signals for Top Stocks - Newser
Mustang Bio Inc.’s volatility index tracking explainedBuy Signal Forecast With Short-Term Data - Newser
Is Mustang Bio Inc. stock bottoming outFree Daily Stock Market Swing Alerts - Newser
Will Mustang Bio Inc. see short term momentumFree ROI Boosting Trade Opportunity Calendar - Newser
How Mustang Bio Inc. stock performs during market volatilityLong Term Stock Planner with Safety Checks - Newser
Mustang Bio Inc Stock (MBIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.11%
1.56%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):